Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Day Range11.200 - 11.430 | 52 Wk Range9.730 - 12.950 | Open / Close11.260 / - | Float / Outstanding84.996M / 153.395M |
Vol / Avg.296.899K / 1.844M | Mkt Cap1.755B | P/E12.043 | 50d Avg. Price11.830 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float84.996M | EPS1.070 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | (EXPECTED) 2023-02-16 | |||||
REV | 117.220M |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.260 | 0.280 | 0.0200 | ||||
REV | 109.110M | 108.637M | -473.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Chinook Therapeutics (NASDAQ:KDNY) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 13.00 expecting IRWD to rise to within 12 months (a possible 13.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $11.44 last updated Today at January 31, 2023 at 5:02 PM UTC.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 16, 2023.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.